Global clinical trial landscape of chimeric antigen receptor T-cell therapy for multiple myeloma: Current status and future trends
Last Updated: Tuesday, February 17, 2026
This article examines the global clinical trial landscape for CAR T-cell therapy in treating multiple myeloma. Researchers from Southwest Medical University analyzed data from the Trialtrove database to provide a comprehensive overview of current progress and emerging future trends in this field. This summary offers valuable clinical insights.
Advertisement
News & Literature Highlights